CORE B ? BIOANALYTICAL, MASS SPECTROSCOPY, IMAGING AND HISTOLOGY CORE PROJECT SUMMARY/ABSTRACT The Cardiorenal and Metabolic Diseases Research Center (CMDRC) was established to enhance research infrastructure and provide mentoring to increase the ability of COBRE investigators to successfully compete for independent NIH funding. The Bioanalytical, Mass Spectroscopy, Imaging and Histology Core B was established as a resource for the CMDRC during Phase I, and this core has had a transformative effect on COBRE junior investigators, Pilot Grant investigators, and investigators from local Historically Black Colleges and Universities (HBCUs). During Phase I of COBRE support, Core B established services critical to cardiorenal and metabolic diseases researchers in addition to numerous investigators who collaborate with members of the CMDRC. Core B provides access to technologies and services that would otherwise not be available in Mississippi. This includes consolidated, highly specialized services and state-of-the-art resources staffed by professional personnel who are not only capable of performing a variety of essential research services, but are also able to provide training and assist in the development of new research methods to meet the changing needs of COBRE investigators. Core B has multiple components including the Bioanalytical/Mass Spec Sub-Cores that provide centralized radioimmunoassay (RIA), ELISA, HPLC, LC/Mass spectroscopy, proteomics, lipidomics and other biochemical/chemistry analyses, and the Histology/Imaging Sub-Cores that provide access to state-of?the-art imaging equipment as well as histology, immunohistochemistry, and other key services. Faculty from over 15 different basic science and clinical departments at UMMC in addition to researchers from other institutions including Jackson State University, a HBCU, used services and resources provided by Core B during Phase I of COBRE support. Resources and services provided by Core B were substantially expanded during Phase I and this was supported by the addition of new state-of-the-art equipment to each Sub-Core. Usage of Core B by investigators facilitated the generation of >250 publications and provided direct support for the receipt of many extramural funded grants from NIH and other non-profit funding agencies. Establishment of Sub-Cores as Recharge Centers initiated our business plan for sustainability and Core B will continue to build upon our success so that we can provide continuous support for existing infrastructure, resources and services, and expand Core offerings to meet the needs of cardiorenal and metabolic disease researchers at UMMC.

Public Health Relevance

CORE B ? BIOANALYTICAL, MASS SPECTROSCOPY, IMAGING AND HISTOLOGY CORE PROJECT NARRATIVE The Bioanalytical, Mass Spectroscopy, Imaging and Histology Core B provides access to technologies and services that would otherwise not be available in Mississippi. This includes the Bioanalytical/Mass Spec Sub- Cores that provide centralized radioimmunoassay (RIA), ELISA, HPLC, LC/Mass spectroscopy, proteomics, lipidomics and other biochemical/chemistry analyses and the Histology and Imaging Sub-Cores that provide access to state-of?the-art imaging equipment as well as histology, immunohistochemistry, in-situ hybridization and other key services. This Core is staffed by professional personnel who are not only capable of performing a variety of essential research services, but are also able to provide training and assist in the development of new research methods to meet the changing needs of COBRE investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory Grants (P20)
Project #
2P20GM104357-06
Application #
9573134
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
2023-04-30
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
6
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Mississippi Medical Center
Department
Type
DUNS #
928824473
City
Jackson
State
MS
Country
United States
Zip Code
39216
Lindsey, Merry L; Mouton, Alan J; Ma, Yonggang (2018) Adding Reg3? to the acute coronary syndrome prognostic marker list. Int J Cardiol 258:24-25
Lindsey, Merry L; Jung, Mira; Hall, Michael E et al. (2018) Proteomic analysis of the cardiac extracellular matrix: clinical research applications. Expert Rev Proteomics 15:105-112
Brooks, Heddwen L; Lindsey, Merry L (2018) Guidelines for authors and reviewers on antibody use in physiology studies. Am J Physiol Heart Circ Physiol 314:H724-H732
Mouton, Alan J; Rivera Gonzalez, Osvaldo J; Kaminski, Amanda R et al. (2018) Matrix metalloproteinase-12 as an endogenous resolution promoting factor following myocardial infarction. Pharmacol Res 137:252-258
Sundararaghavan, Vikram L; Binepal, Sivjot; Stec, David E et al. (2018) Bilirubin, a new therapeutic for kidney transplant? Transplant Rev (Orlando) 32:234-240
Roman, Richard J; Fan, Fan (2018) 20-HETE: Hypertension and Beyond. Hypertension 72:12-18
do Carmo, Jussara M; da Silva, Alexandre A; Moak, Sydney P et al. (2018) Increased sleep time and reduced energy expenditure contribute to obesity after ovariectomy and a high fat diet. Life Sci 212:119-128
Hall, Michael E (2018) Body Mass Index and Heart Failure Mortality: More Is Less? JACC Heart Fail 6:243-245
Lindsey, Merry L (2018) Assigning matrix metalloproteinase roles in ischaemic cardiac remodelling. Nat Rev Cardiol 15:471-479
Turner, Paul A; Garrett, Michael R; Didion, Sean P et al. (2018) Spheroid Culture System Confers Differentiated Transcriptome Profile and Functional Advantage to 3T3-L1 Adipocytes. Ann Biomed Eng 46:772-787

Showing the most recent 10 out of 254 publications